Facebook, Alphabet, Allergan, Amazon, and Apple are widely owned by hedge fund managers.
Acadia's newly approved Parkison's disease drug could trigger a buyout. Here's why.
Comments from another company along the OLED technology food chain point to massive demand coming down the pipeline. And that road goes right through Cupertino.
Shares of the OLED specialist have rallied following massive OLED equipment orders for a certain Cupertino-based tech titan.
Achillion Pharmaceuticals, Ophthotech Corp., and Kite Pharmaceuticals shares could move wildly because of upcoming trial data.
Alphabet, Facebook, Zoetis, Amazon, Priceline, Allergan, and Teva Pharmaceutical are common picks among top hedge fund managers.
Billionaire money managers reduced their holdings in these popular stocks last quarter, but was it a smart move?
Investors shouldn't pay much attention to recent supply-chain rumors purporting to predict iPhone 7 demand.
This platform has been dying for years. Apple delivered the lethal poison, and now Google is simply cremating what remains.
The biotech's numbers are meaningless, but an update on one of its programs sent the stock down.